To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer
Clinical trial NCT07368998 · RECRUITING
Trial details
- NCT number
- NCT07368998
- Sponsor
- Hoffmann-La Roche
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-18
- Primary completion
- 2028-10-31
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.